Synbio Tech Inc. and Cosmax NBT, a major South Korean biotechnology company, officially signed an exclusive cooperation agreement to launch Lactobacillus plantarum TWK10® probiotic strain in South Korea and announced that TWK10® had been approved as an Individual Health Functional Food certification by the Ministry of Food and Drug Safety of South Korea. Under the agreement, COSMAX NBT will exclusively distribute TWK10® in the muscle health category to meet the growing needs of the active nutrition and healthy aging markets.

COSMAX NBT is a subsidiary of COSMAX Group, one of the world’s largest research, development, and production business group for cosmetic and health functional food products. The company specializes in healthcare product OEM services, functional food R&D, and manufacturing and is currently a top leading health functional food ODM company in South Korea. 

KIM SANG WOO, the Vice President of COSMAX NBT says, “According to marketing research, probiotics are one of the most popular health foods among Koreans like red ginseng and vitamins, and the market size of probiotics is expected to grow rapidly at an average annual rate of 16 percent. With Synbio Tech’s innovation in R&D and excellent production technology, the partnership will allow us to further explore collaborative projects to bring outstanding products to the South Korean market.”

Lactobacillus plantarum TWK10® is a probiotic strain strictly selected from Taiwanese fermented cabbage. Extensive studies have confirmed that TWK10® has a significant impact on sports performance, muscle mass, and mobility in older adults through the gut-muscle axis. To date, it has four human clinical trials, seven major global patents, and more than ten international journal publications. It is Taiwan’s first probiotic strain to obtain Individual Health Functional Food certification in South Korea.

Kuiming Lee, the Vice President of Synbio Tech, said, “This collaboration is a very important milestone for Synbio Tech in becoming a global probiotics manufacturer. With the synergy of Synbio Tech and COSMAX NBT, we will further collaborate in scientific research and market development of TWK10® in South Korea.” 

Looking forward to 2023, TWK10® has gradually completed its global launch and distribution across different continents, including Europe, North America, Japan, South Korea, Southeast Asia, and other regions. We will continuously deepen the scientific research of TWK10® and further develop innovative probiotic and postbiotic solutions for better health.